RxDoctor Payments Data

Nicole Schmitt, MD

Plastic Surgery within the Head & Neck · Atlanta, GANPI 1336258086

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $12,100 of the $15,962 with a category attached, or 75.8%. Regeneron accounts for 66.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $9,671 and has fallen 64.0% since, to $3,478 in 2025. Among plastic surgery within the head & neck clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,962in general payments, 2019–2025

Across 30 payments — averaging $532.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$11K
  • Janssen Research & Development, LLC$2K
  • Checkpoint Surgical, Inc$1K
  • Janssen Scientific Affairs, LLC$900
  • Johnson & Johnson$600
  • Kls-martin L.p.$404
  • plus $478 from 4 others
$106,036in research payments, 2019–2025

Across 15 payments — averaging $7069.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Co., Ltd.$103K
  • Taiho Oncology, Inc.$3K

What the payments were for

  • Consulting fees$12,10076%
  • Speaking & faculty fees$1,0006%
  • Travel & lodging$1,4439%
  • Food & beverage$1,4199%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,962 in reported general payments places this provider in the 90th percentile of 24 plastic surgery within the head & neck providers in Georgia.

See all plastic surgery within the head & neck providers in Georgia

Medicare billing

Part B allowed, 2024
$28,531
Medicare patients
80
Services billed
146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl19$201

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →